Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Mir Lim"'
Autor:
David Hsiehchen, Leslie Bucheit, Dong Yang, Muhammad Shaalan Beg, Mir Lim, Sunyoung S. Lee, Pashtoon Murtaza Kasi, Ahmed O. Kaseb, Hao Zhu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-10 (2022)
Abstract Acquired resistance to systemic treatments is inevitable in most cancers, but the genetic basis for this in many cancer types has remained elusive due to constraints in obtaining tissue specimens longitudinally. In the management of gastroin
Externí odkaz:
https://doaj.org/article/10d5b7e68cdf494aa22aacfb1ed0be6a
Autor:
David Hsiehchen, Leslie Bucheit, Dong Yang, Muhammad Shaalan Beg, Mir Lim, Sunyoung S. Lee, Pashtoon Murtaza Kasi, Ahmed O. Kaseb, Hao Zhu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/17dfb71f9364451baa74f6dcefd5dd1d
Autor:
Mir Lim, David S. Shulman, Holly Roberts, Anran Li, Jessica Clymer, Kira Bona, Hasan Al‐Sayegh, Clement Ma, Steven G. DuBois
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6658-6666 (2020)
Abstract Background Off‐label drug prescribing is common in pediatric clinical medicine, though the extent and impact of this practice in pediatric oncology has not yet been characterized. Methods We completed a retrospective single‐institution c
Externí odkaz:
https://doaj.org/article/c0eaf4ca092c4d2a8f696014a5e2ee83
Publikováno v:
Cancer Research. 83:P2-06
BACKGROUND: The Dallas Metastatic Breast Cancer Study (DMBCS) is a clinical database that was established in 2021 at a single academic medical system to track patient demographics, associated pathology, treatments, and other variables that are not wi
Autor:
Mir Lim, Muquith, Maishara, Miramontes, Bernadette, Chieh-Ju Lee, Espinoza, Magdalena, Yi-Hsiang Huang, Hsiehchen, David
Publikováno v:
Hepatology (02709139); Dec2023, Vol. 78 Issue 6, p1755-1762, 8p
Publikováno v:
Urology. 165:242-249
To investigate the effect of radiation treatment at a high-volume center on overall survival in men with intermediate-risk prostate cancer.From 2004 to 2015, 430,347 patients with intermediate-risk prostate cancer were identified in the National Canc
Publikováno v:
Gastroenterology.
Publikováno v:
JCO Precision Oncology.
Autor:
Joseph W Franses, Mir Lim, Adam M Burgoyne, Kabir Mody, Jochen Lennerz, Jeremy Chang, Robin Imperial, Stacey N Dybel, Thi M Dinh, Jude Masannat, Caroline M Weipert, David Hsiehchen
Publikováno v:
The oncologist. 27(11)
Advanced hepatocellular carcinoma (HCC) is responsive to immune checkpoint inhibitors, but there are currently no known biomarkers to predict treatment benefit. Blood TMB (bTMB) estimation via circulating tumor DNA (ctDNA) profiling can provide a con
Publikováno v:
Gastroenterology. 164:1006-1008.e3